Benefitfocus Announces Fourth Quarter and Full Year 2020 Financial Results

Rhea-AI Summary

Benefitfocus, Inc. (NASDAQ: BNFT) reported record Q4 adjusted EBITDA of $20.2 million and GAAP EPS of $0.04, reflecting the company's strategic growth initiatives. Despite achieving all guidance metrics, total revenue of $76.2 million represented a 13% decline year-over-year, with software services declining by 9%. However, the company improved non-GAAP net income to $8.7 million and free cash flow to $13.4 million. For 2021, guidance anticipates revenue between $254 million and $260 million, with adjusted EBITDA projected at $44 million to $50 million.

Positive

• Record Q4 adjusted EBITDA of $20.2 million.
• Non-GAAP net income increased to $8.7 million.
• Free cash flow rose to $13.4 million.
• Augmented leadership with a new chief data officer.

Negative

• Total revenue decreased 13% year-over-year.
• Subscription revenue fell by 9% compared to Q4 2019.
• Professional services revenue dropped 26% year-over-year.

Delivers record Q4 adjusted EBITDA of $20.2 million, GAAP EPS of $0.04 and non-GAAP EPS of $0.18
Executing on clear priorities to drive growth and operating leverage

CHARLESTON, S.C., March 08, 2021 (GLOBE NEWSWIRE) -- Benefitfocus, Inc. (NASDAQ: BNFT), an industry-leading  benefits technology platform that simplifies benefits administration for employers, health plans and brokers, today announces its fourth quarter and full year 2020 financial results.  

Highlights include: 

• Met or exceeded all fourth quarter and full year 2020 guidance metrics including revenue, adjusted EBITDA and free cash flow;
• Augmented leadership team with hiring of first chief data officer to solidify the company as a leading, data-driven benefits technology platform;
• Enhanced Benefit Catalog including partnership with Transamerica to enable integrated retirement plan enrollment directly through Benefitplace™;
• Invested to remove friction in benefits management and improve the customer experience through AI-backed platform enrollment enhancements; and
• Strengthened corporate governance and continued to enhance independence of company’s board structure.

“Benefitfocus continues to execute on its strategies to drive industry leadership and accelerate growth,” said Steve Swad, president and chief executive officer of Benefitfocus. “The investments we made in operational excellence, automation and enhanced customer interactions resulted in our best open enrollment yet.” Swad added, “To drive future growth, we are focused on simplifying the enrollment of benefits, improving our customers’ engagement with their benefits, and using data to personalize our offerings and create products that lower health care costs. I am confident we have the right strategy, the right assets and are building the right leadership team to unlock substantial shareholder value.”

“For the fourth quarter and full year, we delivered record EBITDA and free cash flow, moving us further towards our goal to become the most efficient and best-performing company in our industry,” said Alpana Wegner, chief financial officer of Benefitfocus. “I am pleased with the strong foundation we have established to deliver increased profitability and free cash flow, and remain focused on driving continued operating leverage in the business.”

Fourth Quarter 2020 Financial Highlights

Revenue

• Total revenue was $76.2 million, down 13% compared to the fourth quarter of 2019.
  
  
• Software services was $62.3 million, 9% lower compared to the fourth quarter of 2019. Software services is comprised of subscription and platform revenue.
  
  • Subscription revenue was $44.9 million, a decrease of 9% compared to the fourth quarter of 2019.
  
  • Platform revenue was $17.4 million, a decrease of 8% compared to the fourth quarter of 2019.
  
  
• Professional services revenue was $13.9 million, down 26% compared to the fourth quarter of 2019.

Net Income (Loss)

• GAAP net income was $3.1 million, compared to ($3.8) million in the fourth quarter of 2019. GAAP net income per share was $0.04, based on $1.3 million net income available to common stockholders and 33.5 million fully diluted weighted average common shares outstanding, compared to ($0.12) for the fourth quarter of 2019, based on ($3.8) million net loss available to common stockholders and 32.8 million basic and diluted weighted average common shares outstanding.

Non-GAAP Net Income, Adjusted EBITDA and Free Cash Flow

• Non-GAAP net income was $8.7 million compared to $1.9 million in the fourth quarter of 2019. Non-GAAP net income per share was $0.18, based on $6.1 million net income available to common stockholders and 34.5 million fully diluted weighted average common shares outstanding, compared to $0.06 in the fourth quarter of 2019, based $1.9 million net income available to common stockholders and 33.2 million fully diluted weighted average common shares outstanding.
  
  
• Adjusted EBITDA was $20.2 million, compared to $12.5 million in the fourth quarter of 2019.
  
  
• Free cash flow was $13.4 million, compared to $2.5 million in the fourth quarter of 2019.

See important disclosures about non-GAAP measures, and a reconciliation of them to GAAP, below.

Full Year 2020 Financial Highlights

Revenue

• Total revenue was $268.1 million, down 9% compared to the full year 2019.
  
  
• Software services was $214.8 million, 6% lower compared to the full year 2019. Software services is comprised of subscription and platform revenue.
  
  • Subscription revenue was $179.7 million, a decrease of 8% compared to the full year 2019.
  
  • Platform revenue was $35.1 million, an increase of 4% compared to the full year 2019.
  
  
• Professional services revenue was $53.3 million, down 20% compared to the full year 2019.

Net Loss

• GAAP net loss was ($24.3) million, compared to ($45.5) million in the full year 2019. GAAP net loss per share was ($0.87), based on ($28.0) million net loss available to common stockholders and 32.3 million basic and diluted weighted average common shares outstanding, compared to ($1.40) for the full year 2019, based on ($45.5) million net loss available to common stockholders and 32.5 million basic and diluted weighted average common shares outstanding.

Non-GAAP Net Loss, Adjusted EBITDA and Free Cash Flow

• Non-GAAP net loss was ($6.8) million, compared to ($22.3) million in the full year 2019. Non-GAAP net loss per share was ($0.32), based on ($10.5) million Non-GAAP net loss available to common stockholders and 32.3 million basic and diluted weighted average common shares outstanding, compared to ($0.69) for the full year 2019, based on ($22.3) million net loss available to common stockholders and 32.5 million basic and diluted weighted average common shares outstanding.
  
  
• Adjusted EBITDA was $44.0 million, compared to $19.0 million in the full year 2019.
  
  
• Free cash flow was $19.9 million, compared to ($31.6) million in the full year 2019.

See important disclosures about non-GAAP measures, and a reconciliation of them to GAAP, below.

Balance Sheet

• Cash and cash equivalents and marketable securities at December 31, 2020 totaled $185.8 million, compared to $176.0 million at the end of the third quarter of 2020. 
  
  
• The full $50.0 million line of credit remains available to the Company.

Business Outlook

Based on information available as of March 8, 2021, Benefitfocus is providing guidance for the first quarter and full year 2021 as indicated below. Adjusted EBITDA and free cash flow guidance excludes the impact of restructuring charges.

First Quarter 2021

• Total revenue is expected to be in the range of $59 million to $61 million.
  
  
• Adjusted EBITDA is expected to be in the range of $9 million to $11 million.
  
  
• Non-GAAP net loss is expected to be between $5.1 and $3.1 million, or between ($0.16) and ($0.10) per share based on 32.3 million basic shares outstanding.

Full Year 2021

• Total revenue is expected to be in the range of $254 million to $260 million.
  
  
• Adjusted EBITDA is expected to be in the range of $44 million to $50 million.
  
  
• Free cash flow is expected to be in the range of $20 million to $26 million.

In addition, Benefitfocus is providing mid-term financial targets and an update on continued enhancements to the company’s board structure as part of its conference call today.

Management has not reconciled forward-looking non-GAAP net loss, adjusted EBITDA or free cash flow to their most directly comparable GAAP measure of GAAP net loss or GAAP operating cash flows. This is because we cannot predict with reasonable certainty the ultimate outcome of the various necessary GAAP components of such reconciliations, including, for example, those related to compensation, acquisition transactions and integration, or others that may arise during the year, without unreasonable effort. These components and other factors could materially impact the amount of the future directly comparable GAAP measures, which may differ significantly from their non-GAAP counterparts. See below for additional important disclosures regarding our non-GAAP financial measures.

Conference Call Details:

In conjunction with this announcement, Benefitfocus will host a conference call to discuss the company’s financial results and business outlook on Monday, March 8, 2021, at 5:00 p.m. ET. To access this call, dial (877) 407-9208 (domestic) or (201) 493-6784 (international). A live webcast of the conference call will be available on the Investor Relations page of the company’s website at http://investor.benefitfocus.com/. After the conference call, a replay will be available until March 15, 2021, and can be accessed by dialing (844) 512-2921 (domestic) or (412) 317-6671 (international) with passcode 13715704.

About Benefitfocus

Benefitfocus (NASDAQ: BNFT) unifies the entire U.S. benefits industry on a single technology platform to protect consumers' health, wealth, property and lifestyle. Our powerful cloud-based software, data-driven insights and thoughtfully-designed services, enable employers, insurance brokers, carriers and suppliers to simplify the complexity of benefits administration and deliver a world-class benefits experience. Learn more at www.benefitfocus.com, LinkedIn and Twitter.

Non-GAAP Financial Measures

The company uses certain non-GAAP financial measures in this release, including non-GAAP gross profit, operating income/loss, net loss/income, net loss/income per common share, adjusted EBITDA and free cash flow. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance or financial position that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. 

Non-GAAP gross profit, operating income/loss, net loss/income and net loss/income per common share exclude stock-based compensation expenses, amortization of acquisition-related intangible assets, transaction and acquisition-related costs expensed, restructuring charges, expense related to the impairment of goodwill, intangible assets and long-lived assets, gain or loss on extinguishment of debt, and costs not core to our business. We define adjusted EBITDA as net loss before net interest, taxes, and depreciation and amortization expense, adjusted to eliminate stock-based compensation expense, expense related to the impairment of goodwill, intangible assets and long-lived assets, transaction and acquisition-related costs expensed, restructuring charges, gain or loss on extinguishment of debt, and costs not core to our business. We define free cash flow as cash used in operating activities less capital expenditures, adjusted to eliminate restructuring charges. Beginning in the fourth quarter of 2020, we revised our definition of non-GAAP net loss/income and net loss/income per common share to also exclude expense related to the impairment of goodwill, intangible assets and long-lived assets.  Additionally, we revised our definition of adjusted EBITDA  to also exclude expense related to the impairment of long-lived assets, restructuring charges and gains or loss on extinguishment of debt.  The revisions to these definitions had no impact on our reported non-GAAP net loss/income and net loss/income per common share and adjusted EBITDA for periods prior to the three months ended December 31, 2020. Please note that other companies might define their non-GAAP financial measures differently than we do.

Management presents these non-GAAP financial measures in this release because it considers them to be important supplemental measures of performance. Management uses these non-GAAP financial measures for planning purposes, including analysis of the company's performance against prior periods, the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management believes that these non-GAAP financial measures provide additional insight for analysts and investors in evaluating the company's financial and operational performance. Management also intends to provide these non-GAAP financial measures as part of the company’s future earnings discussions and, therefore, their inclusion should provide consistency in the company’s financial reporting.

Non-GAAP financial measures have limitations as an analytical tool. Investors are encouraged to review the reconciliation of the non-GAAP measures to their most directly comparable GAAP measures provided in this release, including in the accompanying tables.

Safe Harbor Statement

Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: volatility and uncertainty in the global economy and financial markets in light of the evolving COVID-19 pandemic and uncertainties arising from the recent U.S. elections; our continuing losses and need to achieve GAAP profitability; fluctuations in our financial results; our ability to maintain our culture, retain and motivate qualified personnel; the immature and volatile market for our products and services; risks related to changing healthcare and other applicable regulations; risks associated with acquisitions; cyber-security risks; the need to innovate and provide useful products and services; our ability to compete effectively; privacy, security and other risks associated with our business; and the other risk factors set forth from time to time in our SEC filings, copies of which are available free of charge within the Investor Relations section of the Benefitfocus website at http://investor.benefitfocus.com/sec-filings or upon request from our Investor Relations Department. Benefitfocus assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

Source: Benefitfocus, Inc.

Benefitfocus, Inc.
Consolidated Statements of Operations and Comprehensive Loss
(in thousands, except share and per share data)
		Three Months Ended								Year Ended
		December 31,								December 31,
			2020				2019				2020				2019
Revenue		$	76,230			$	87,143			$	268,141			$	295,686
Cost of revenue (1)(2)(3)			34,966				42,848				129,388				144,090
Gross profit			41,264				44,295				138,753				151,596
Operating expenses:(1)(2)(3)
Sales and marketing			12,347				18,585				52,210				76,049
Research and development			11,923				13,085				46,175				54,724
General and administrative			8,400				10,976				37,720				45,329
Restructuring costs			–				–				5,616				–
Total operating expenses			32,670				42,646				141,721				176,102
Income (loss) from operations			8,594				1,649				(2,968	)			(24,506	)
Other income (expense):
Interest income			69				518				632				2,613
Interest expense			(5,547	)			(5,947	)			(23,071	)			(23,524	)
Gain on repurchase of convertible senior notes			–				–				1,138				–
Other (expense) income			(14	)			(10	)			(6	)			(71	)
Total other expense, net			(5,492	)			(5,439	)			(21,307	)			(20,982	)
Income (loss) before income taxes			3,102				(3,790	)			(24,275	)			(45,488	)
Income tax expense			5				1				22				27
Net income (loss)			3,097				(3,791	)			(24,297	)			(45,515	)
Preferred dividends			(1,600	)			–				(3,662	)			–
Undistributed earnings allocated to preferred stockholders			(212	)			–				–				–
Net income (loss) available to common stockholders		$	1,285			$	(3,791	)		$	(27,959	)		$	(45,515	)
Comprehensive income (loss)		$	3,097			$	(3,791	)		$	(24,297	)		$	(45,515	)
Net income (loss) per common share:
Basic		$	0.04			$	(0.12	)		$	(0.87	)		$	(1.40	)
Diluted		$	0.04			$	(0.12	)		$	(0.87	)		$	(1.40	)
Weighted-average common shares outstanding:
Basic			32,312,246				32,774,924				32,318,201				32,539,748
Diluted			33,512,904				32,774,924				32,318,201				32,539,748
(1) Stock-based compensation included in above line items:
Cost of revenue		$	1,099			$	1,181			$	3,703			$	3,569
Sales and marketing			841				1,202				3,081				3,799
Research and development			838				665				2,555				3,265
General and administrative			900				2,023				5,198				8,939
(2) Amortization of acquired intangible assets included in above line items:
Cost of revenue		$	330			$	317			$	1,291			$	1,029
Sales and marketing			75				91				331				337
Research and development			118				111				460				400
General and administrative			46				50				192				167

Benefitfocus, Inc.
Consolidated Balance Sheets
(in thousands, except share and per share data)
		As of December 31,
		2020				2019
Assets
Current assets:
Cash and cash equivalents		$	90,706			$	130,976
Marketable securities			95,085				–
Accounts receivable, net			22,240				33,754
Contract, prepaid and other current assets			21,354				21,523
Total current assets			229,385				186,253
Property and equipment, net			29,701				28,669
Financing lease right-of-use assets			68,670				78,520
Operating lease right-of-use assets			1,107				1,715
Intangible assets, net			10,393				12,667
Goodwill			12,857				12,857
Deferred contract costs and other non-current assets			10,259				11,002
Total assets		$	362,372			$	331,683
Liabilities and stockholders' deficit
Current liabilities:
Accounts payable		$	2,160			$	9,563
Accrued expenses			6,262				10,526
Accrued compensation and benefits			19,129				15,246
Deferred revenue, current portion			27,782				33,429
Lease liabilities and financing obligations, current portion			5,959				6,871
Total current liabilities			61,292				75,635
Deferred revenue, net of current portion			4,422				5,079
Convertible senior notes			184,308				187,949
Lease liabilities and financing obligations, net of current portion			79,282				88,572
Other non-current liabilities			2,470				92
Total liabilities			331,774				357,327
Commitments and contingencies
Redeemable preferred stock:
Series A preferred stock, par value $0.001, 5,000,000 shares authorized, 1,777,778 and 0 shares issued and outstanding at December 31, 2020 and 2019, respectively, liquidation preference $45 per share as of December 31, 2020			79,193				–
Stockholders' deficit:
Common stock, par value $0.001, 50,000,000 shares authorized, 32,327,439 and 32,788,980 shares issued and outstanding at December 31, 2020 and 2019, respectively			32				33
Additional paid-in capital			427,431				426,025
Accumulated deficit			(476,058	)			(451,702	)
Total stockholders' deficit			(48,595	)			(25,644	)
Total liabilities, redeemable preferred stock and stockholders' deficit		$	362,372			$	331,683

Benefitfocus, Inc.
Consolidated Statements of Cash Flows
(in thousands)
		Year Ended December 31,
			2020				2019				2018
Cash flows from operating activities
Net loss		$	(24,297	)		$	(45,515	)		$	(52,627	)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:
Depreciation and amortization			25,014				22,351				15,815
Stock-based compensation expense			14,537				19,572				28,868
Accretion of interest on convertible senior notes			11,656				11,256				–
Interest accrual on finance lease liabilities			97				33				–
Interest accrual on financing obligations (prior to adoption of ASC 842)			–				–				7,521
Rent payments in excess of expense			(32	)			(16	)			–
Non-cash interest income for short-term investments			143				–				–
Loss on disposal or impairment of property and equipment			918				9				7
Gain on extinguishment of debt			(1,138	)			–				–
Provision for doubtful accounts			43				111				364
Changes in operating assets and liabilities:
Accounts receivable, net			11,412				(11,875	)			8,650
Accrued interest on short-term investments			(102	)			–				–
Contract, prepaid and other current assets			169				(3,642	)			(570	)
Deferred costs and other non-current assets			743				2,893				3,137
Accounts payable and accrued expenses			(11,468	)			426				6,566
Accrued compensation and benefits			3,884				161				649
Deferred revenue			(6,304	)			(14,047	)			(9,165	)
Other non-current liabilities			2,376				(92	)			(234	)
Net cash and cash equivalents provided by (used in) operating activities			27,651				(18,375	)			8,981
Cash flows from investing activities
Purchases of short-term investments held to maturity			(104,125	)			–				–
Proceeds from short-term investments held to maturity			9,000				–				–
Business combination, net of cash acquired			–				(20,914	)			–
Purchases of property and equipment			(13,085	)			(13,248	)			(8,290	)
Net cash and cash equivalents used in investing activities			(108,210	)			(34,162	)			(8,290	)
Cash flows from financing activities
Draws on revolving line of credit			10,000				–				115,000
Payments on revolving line of credit			(10,000	)			–				(171,246	)
Proceeds from issuance of convertible senior notes			–				–				240,000
Repurchase of convertible senior notes			(14,619	)			–				–
Payments of debt issuance costs			(154	)			(357	)			(6,000	)
Purchase of convertible note capped call hedge			–				–				(33,024	)
Cancellation of convertible note capped call hedge			26				–				–
Proceeds from issuance of preferred stock, net of issuance costs			79,192				–				–
Payment of preferred dividends			(3,662	)			–				–
Repurchase of common stock			(9,667	)			–				–
Proceeds from exercises of stock options and ESPP			585				453				712
Payments on capital lease and financing obligations			(1,212	)			(1,627	)			(10,540	)
Payments of principal on finance lease liabilities			(10,200	)			(5,884	)			–
Net cash and cash equivalents provided by (used in) financing activities			40,289				(7,415	)			134,902
Net (decrease) increase in cash and cash equivalents			(40,270	)			(59,952	)			135,593
Cash and cash equivalents, beginning of year			130,976				190,928				55,335
Cash and cash equivalents, end of year		$	90,706			$	130,976			$	190,928
Supplemental disclosure of non-cash investing and financing activities
Property and equipment purchases in accounts payable and accrued expenses		$	142			$	154			$	244
Property and equipment purchased with financing and capital lease obligations (prior to adoption of ASC 842)		$	-			$	-			$	4,810
Post contract support purchased with financing obligations		$	-			$	1,287			$	790
Debt issuance costs included in accounts payable and accrued expenses		$	-			$	-			$	358
Supplemental disclosure of cash flow information
Income taxes paid		$	22			$	28			$	28
Interest paid		$	11,408			$	12,374			$	11,884

Benefitfocus, Inc.
Reconciliation of GAAP to Non-GAAP Measures
(unaudited, dollars in thousands except share and per share data)
		Three Months Ended December 31,								Year Ended December 31,
		2020				2019				2020				2019
Reconciliation from Gross Profit to Non-GAAP Gross Profit:
Gross profit		$	41,264			$	44,295			$	138,753			$	151,596
Amortization of acquired intangible assets			330				317				1,291				1,029
Stock-based compensation expense			1,099				1,181				3,703				3,569
Impairment of long-lived assets			468				—				468				—
Total net adjustments			1,897				1,498				5,462				4,598
Non-GAAP gross profit		$	43,161			$	45,793			$	144,215			$	156,194
Reconciliation from Operating Income (Loss) to Non-GAAP Operating Income (Loss):
Operating income (loss)		$	8,594			$	1,649			$	(2,968	)		$	(24,506	)
Amortization of acquired intangible assets			569				569				2,274				1,933
Stock-based compensation expense			3,678				5,071				14,537				19,572
Transaction and acquisition-related costs expensed			25				30				450				1,035
Impairment of long-lived assets			916				—				916				—
Costs not core to our business			457				—				457				649
Total net adjustments			5,645				5,670				18,634				23,189
Non-GAAP operating income (loss)		$	14,239			$	7,319			$	15,666			$	(1,317	)
Reconciliation from Net Income (Loss) to Adjusted EBITDA:
Net income (loss)		$	3,097			$	(3,791	)		$	(24,297	)		$	(45,515	)
Depreciation			3,789				3,783				15,285				15,288
Amortization of software development costs			2,177				1,370				7,455				5,130
Amortization of acquired intangible assets			569				569				2,274				1,933
Interest income			(69	)			(518	)			(632	)			(2,613	)
Interest expense			5,547				5,947				23,071				23,524
Income tax expense			5				1				22				27
Stock-based compensation expense			3,678				5,071				14,537				19,572
Transaction and acquisition-related costs expensed			25				30				450				1,035
Restructuring costs			—				—				5,616				—
Impairment of long-lived assets			916				—				916				—
Gain on repurchase of convertible senior notes			—				—				(1,138	)			—
Costs not core to our business			457				—				457				649
Total net adjustments			17,094				16,253				68,313				64,545
Adjusted EBITDA		$	20,191			$	12,462			$	44,016			$	19,030
Reconciliation from Net Income (Loss) to Non-GAAP Net Income (Loss):
Net income (loss)		$	3,097			$	(3,791	)		$	(24,297	)		$	(45,515	)
Amortization of acquired intangible assets			569				569				2,274				1,933
Stock-based compensation expense			3,678				5,071				14,537				19,572
Transaction and acquisition-related costs expensed			25				30				450				1,035
Impairment of long-lived assets			916				—				916				—
Gain on repurchase of convertible senior notes			—				—				(1,138	)			—
Costs not core to our business			457				—				457				649
Total net adjustments			5,645				5,670				17,496				23,189
Non-GAAP net income (loss)		$	8,742			$	1,879			$	(6,801	)		$	(22,326	)
Calculation of Non-GAAP Earnings Per Share:
Non-GAAP net income (loss)		$	8,742			$	1,879			$	(6,801	)		$	(22,326	)
Preferred dividends			(1,600	)			—				(3,662	)			—
Undistributed earnings allocated to preferred stockholders			(1,012	)			—				—				—
Non-GAAP net income (loss) available to common stockholders		$	6,130			$	1,879			$	(10,463	)		$	(22,326	)
Weighted average shares outstanding - basic			32,312,246				32,774,924				32,318,201				32,539,748
Weighted average shares outstanding - diluted			34,556,833				32,774,924				32,318,201				32,539,748
Shares used in computing non-GAAP net income (loss) per share - basic			32,312,246				32,774,924				32,318,201				32,539,748
Shares used in computing non-GAAP net income (loss) per share - diluted			33,512,904				33,209,220				32,318,201				32,539,748
Non-GAAP net income (loss) per common share - basic		$	0.19			$	0.06			$	(0.32	)		$	(0.69	)
Non-GAAP net income (loss) per common share - diluted		$	0.18			$	0.06			$	(0.32	)		$	(0.69	)
Reconciliation of Cash Flows from Operations to Free Cash Flow:
Net cash and cash equivalents provided by (used in) operating activities		$	16,577			$	5,140			$	27,651			$	(18,375	)
Purchases of property and equipment			(3,346	)			(2,644	)			(13,085	)			(13,248	)
Cash paid for restructuring costs			141				—				5,342				—
Total net adjustments			(3,205	)			(2,644	)			(7,743	)			(13,248	)
Free Cash Flow		$	13,372			$	2,496			$	19,908			$	(31,623	)

Benefitfocus, Inc.
843-981-8898
pr@benefitfocus.com

Investor Relations:
Patti Leahy
843-981-8899
ir@benefitfocus.com   

FAQ

What were Benefitfocus' Q4 2020 financial results?

Benefitfocus reported Q4 2020 total revenue of $76.2 million, a 13% decrease year-over-year, with adjusted EBITDA of $20.2 million.

What is the GAAP EPS for Benefitfocus in Q4 2020?

The GAAP EPS for Q4 2020 was $0.04.

What is the revenue outlook for Benefitfocus in 2021?

Benefitfocus expects total revenue in 2021 to be between $254 million and $260 million.

How did Benefitfocus perform financially compared to 2019?

Compared to 2019, total revenue for the full year 2020 decreased by 9%, while adjusted EBITDA improved significantly.

What are the projected adjusted EBITDA figures for Benefitfocus in Q1 2021?

For Q1 2021, adjusted EBITDA is expected to be in the range of $9 million to $11 million.